Dr. AbouGhaddara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-1000
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2018 - 2020
- American University of Beirut Faculty of MedicineClass of 2013
Certifications & Licensure
- OH State Medical License 2020 - 2026
- GA State Medical License 2019 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- 3 citationsA pilot randomized trial to evaluate the efficacy of oral and nasal povidone iodine in reducing the burden of severe acute respiratory syndrome coronavirus 2 RNA in pa...Sarah N Redmond, Daniel F Li, Hussein Abou Ghaddara, Muhammed F Haq, Lucas D Jones
Infection Control and Hospital Epidemiology. 2023-04-01 - 8 citationsAssessing concordance of financial conflicts of interest disclosures with payments' databases: a systematic survey of the health literature.Hebah M. El-Rayess, Assem M. Khamis, Sara Haddad, Hussein Abou Ghaddara, Maram B Hakoum
Journal of Clinical Epidemiology. 2020-07-03 - 19 citationsEfficacy of a povidone iodine preparation in reducing nasal methicillin-resistant Staphylococcus aureus in colonized patients.Hussein Abou Ghaddara, Jessica A. Kumar, Jennifer L. Cadnum, Yilen K Ng-Wong, Curtis J. Donskey
American Journal of Infection Control. 2020-04-01
Abstracts/Posters
- Evaluation of a Povidone-Iodine Preparation for Nasal Decolonization of Methicillin-Resistant Staphylococcus aureusHussein Abou Ghaddara, MD, Jennifer Cadnum, BS, Y Karen Ng Wong, MD, Curtis Donskey, MD, Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S269, 10/23/2019
- First Report of NRAS Mutations Contributing to Donor Cell Leukemia after allogeneic Bone Marrow Transplantation for Severe Aplastic AnemiaRita Assi, Rami Mahfouz, Hussein Abou Ghaddara, Ali Bazarbachi, Clinical Lymphoma, Myeloma and Leukemia 15:S240, 5/2015
- Azacitidine Maintenance after Allogeneic Stem Cell Transplantation Is Feasible in Patients with Acute Myeloid Leukemia and MyelodysplasiaAhmad Antar, MD , Mohamed A Kharfan-Dabaja, MD , Hussein Abou Ghaddara, MD , Rami Mahfouz, MD MPH , Ali Bazarbachi, MD PhD, Blood (2014) 124 (21): 5884., 12/6/2014
- Join now to see all
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: